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Abstract
Background: The number of extended-spectrum beta-lactamase (ESBL) positive (+) Escherichia coli is increasing worldwide.
In contrast with many other multidrug-resistant bacteria, it is suspected that they predominantly spread within the
community. The objective of this study was to assess factors associated with community-acquired colonization of ESBL (+) E.
coli.
Methods: We performed a matched case-control study at the Charité University Hospital Berlin between May 2011 and
January 2012. Cases were defined as patients colonized with community-acquired ESBL (+) E. coli identified ,72 h after
hospital admission. Controls were patients that carried no ESBL-positive bacteria but an ESBL-negative E.coli identified
,72 h after hospital admission. Two controls per case were chosen from potential controls according to admission date.
Case and control patients completed a questionnaire assessing nutritional habits, travel habits, household situation and
language most commonly spoken at home (mother tongue). An additional rectal swab was obtained together with the
questionnaire to verify colonization status. Genotypes of ESBL (+) E. coli strains were determined by PCR and sequencing.
Risk factors associated with ESBL (+) E. coli colonization were analyzed by a multivariable conditional logistic regression
analysis.
Results: We analyzed 85 cases and 170 controls, respectively. In the multivariable analysis, speaking an Asian language most
commonly at home (OR = 13.4, CI 95% 3.3–53.8; p,0.001) and frequently eating pork ($3 meals per week) showed to be
independently associated with ESBL colonization (OR = 3.5, CI 95% 1.8–6.6; p,0.001). The most common ESBL genotypes
were CTX-M-1 with 44% (n = 37), CTX-M-15 with 28% (n = 24) and CTX-M-14 with 13% (n = 11).
Conclusion: An Asian mother tongue and frequently consuming certain types of meat like pork can be independently
associated with the colonization of ESBL-positive bacteria. We found neither frequent consumption of poultry nor previous
use of antibiotics to be associated with ESBL colonization.
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Introduction
The prevalence of 3rd generation cephalosporin resistance
among gram negative bacteria has increased worldwide in recent
years [1]. The predominant resistance mechanism is the produc-
tion of extended-spectrum beta-lactamase (ESBL). In contrast with
other multidrug-resistant bacteria, it is suspected that the ESBL-
mediated resistance has been spreading mainly throughout the
community and not primarily within healthcare-related institu-
tions. Travel to endemic countries is an often-discussed risk factor
for ESBL colonization [2,3]. Another basis for discussion are the
results of recent studies that have shown frequent ESBL
colonization in poultry. This suggests spread through the food
chain [4,5,6,7]. To assess these factors we performed a case-
control study comparing people who acquired ESBL-positive




A confirmatory ethics vote was obtained from the Charité
University Medicine ethics committee (processing number EA4/
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022/11). Following the Charité University Medicine ethics
committee, study subjects had to be at least 18 years of age and
were recruited from the Charité University Hospital. Written
informed consent was obtained from all subjects. We categorized
subjects into cases (colonized with ESBL-positive E. coli) and
controls (not colonized with an ESBL positive organism but
colonized with ESBL negative E. coli) irrespective of any socially
constructed grouping (e.g. race/ethnicity, age, disease/disabilities,
religion, sex/gender or sexual orientation).
Setting, Study Design and Questionnaire
The case control study was performed at the Charité University
Hospital in Berlin, Germany, a tertiary care university hospital
with over 120,000 inpatients per year. The study was designed to
detect an odds ratio greater than or equal to 4 with a significance
level of 0.05 and a power of 0.80. According to the ECDC report
on antimicrobial resistance in Europe, we assumed an ESBL
colonization rate of 6% [8]. Based on these requirements 79 cases
and 158 controls should be observed. Cases and controls were
selected from the Charité patient population in a study period of
nine months (May 2011 to January 2012). Patients included were
interviewed by our study staff members who obtained informed
consent, a completed study questionnaire and a rectal swab. The
study questionnaire enquired the patients’ age, sex, body mass
index (BMI), living situation (alone, shared apartment with a
vegetarian/meat eater) and animal contact. Furthermore, we
assessed healthcare-related risk factors like antimicrobial therapy
and hospital stay, and further related risk factors like urinary tract
infections, diarrhea (each within the last 12 months) and
colonization with methicillin-resistant S. aureus (MRSA), vanco-
mycin resistant Enterococci (VRE) or Clostridium difficile within the
prior 12 months [9,10,11]. We also included the patients’ travel
destinations within the last 12 months, as well as the most
commonly spoken language in the patients’ home. For easier
reference in this article we refer to this parameter as the patients’
mother tongue. Dietary habits were estimated by assessing the
average number of meals with beef, pork, poultry and fish meals
per week within the last 12 months. Except underlying co-
morbidities, all patient parameters were assessed through the
interview questionnaire. As a measurement for underlying co-
morbidities, the Charlson co-morbidity index (CCI) was obtained
by analyzing the patients’ electronic files.
Cases and Controls
Cases and controls had to be at least 18 years of age. They were
found by search of the database of the Charité department of
microbiology. Cases were defined as patients that carried ESBL -
positive E. coli (confirmed ESBL phenotype) and controls were
defined as patients that carried no ESBL-positive bacteria but an
ESBL-negative E.coli. Both were found in a clinically obtained
specimen within the first 72 hours after admission. We considered
all types of specimen (urine culture, blood culture, rectal swab,
stool sample etc.) that were sent to the microbiology laboratory
within the study period for microbiological examination to be
clinically obtained specimens. All potential cases and controls that
were colonized with an ESBL-positive bacterium in a previous
hospital stay within the last 12 months were excluded. Each case
was matched to two controls. In order to verify the colonization
status at the time of enquiry, we obtained an additional rectal swab
at the interview (verification swab). The study was approved in
advance by the Charité ethics commission.
Microbiological Methods
For initial identification of cases and controls, bacterial strains
were tested using the Vitek 2 automated system. Susceptibility
testing of ESBL-positive bacteria was performed as minimal
inhibitory concentration (MIC) and included testing of cefotaxim,
ceftriaxon and ceftazidime. Confirmation of ESBL production was
performed by a MIC dilution test on a multi-well microtiter plate.
3rd generation cephalosporins were tested alone and in combina-
tion with clavulanic acid. All verification swabs were inoculated
onto chrom ID ESBL agar (BioMerieux). ESBL-positive isolates
were affirmed by Double Disc Synergie Testing using 3rd
generation cephalosporins with/without clavulanic acid (Mast).
Species confirmation was done by API20E (BioMerieux). All E. coli
isolates with confirmed ESBL phenotype were further analyzed by
the Robert Koch Institute, Wernigerode, Germany. Antimicrobial
susceptibilities to 12 different antibiotics (ampicillin, cefotaxime,
ceftazidime, cefoxitin, nalidixic acid, ciprofloxacin, gentamicin,
amikacin, streptomycin, chloramphenicol, tetracycline, and tri-
methoprim-sulfamethoxazole) were performed according to CLSI
criteria [12]. Presence of beta-lactamase genes was tested by PCR
amplification and sequencing of ESBL genes blaTEM, blaSHV,
blaCTX-M [13,14]. In isolates with minimum inhibitory concentra-
tions (MICs) for ciprofloxacin (MICCIP = 0.125– .64 mg/L), the
presence of plasmid-mediated quinolone resistance (PMQR) genes
(qnr-type genes, aac(69)1b-cr) was determined [7,14]. E. coli
phylogenetic groups were identified by a previously described
PCR-based method [15].
Statistical Methods
Categorical variables were compared and tested using the Chi-
square test. Continuous variables were compared and tested using
the Wilcoxon rank sum test. A multivariable analysis was
performed to estimate the effects of factors independently
associated with ESBL-positive E. coli colonization using a stepwise
forward conditional logistic regression. The p-values for including
a variable in the model was 0.05 and for excluding 0.06
respectively. Odds ratios (OR) and their 95% confidence intervals
(CI 95%) were calculated. SPSS (IBM SPSS statistics, Somer, NY,
USA) and SAS (SAS Institute, Cary, NC, USA) were used for
these analyses.
Results
We collected data on all consecutive cases colonized with ESBL
positive-E.coli during the study period, altogether 227 patients.
Sixty-four patients had to be excluded due to prior nosocomial
acquisition of ESBL, 51 patients could not be interviewed due to
medical condition (intubation, dementia, fatal condition), and 21
patients were not available for the interview due to early discharge
or denial of study participation. Six patients were furthermore
excluded because they carried an ESBL-positive enterohemor-
rhagic E.coli (EHEC) and were part of the EHEC outbreak that
took place in Germany during the study period [16]. Eighty-five
patients met our definition of community-acquired ESBL-positive
E.coli and were eligible. Seven-hundred ninety-seven potential
controls were eligible for further individual screening and one-
hundred seventy-three controls were finally available as controls.
We matched two controls to one case. If more than two controls
were eligible, we selected the control with the closest admission
date to the respective case admission date. A flow diagram
documenting the recruitment process for cases and controls is
displayed in Figure 1. The analysis of base line parameter for
included and excluded patients is shown in Table 1. There were
no differences in the baseline parameters between cases and
Risk Factors for ESBL Colonization
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controls (Table 2). The results of the questionnaire based interview
are shown in Table 3. None of the included patients lived on a
vegan or vegetarian diet. There was neither difference in the living
situation nor in the animal contact or health care-related risk
factors between of cases and controls. In the multivariable
conditional logistic regression analysis for ESBL colonization,
Asian mother tongue (Odds ratio 13.4, IC 95% 3.3–53.8, p-value
,0.001) and frequent consumption of pork (Odds ratio 3.5, CI
95% 1.8–6.6, p-value ,0.001) were independently associated with
the colonization of ESBL-positive E. coli (Table 4). Of the 11 case
patients with Asian mother tongue, only one consumed pork. This
person was also among the group of frequent pork meat
consumers and had an Eastern Asian mother tongue. To identify
cases of household transmission, we controlled these 11 patients
for familiar relations by surname and postal code. No similarities
were found. Among the 50 patients with frequent pork meat
consumption, 96% (n = 48) gave German as their mother tongue.
Molecular analyses revealed CTX-M-type ESBL in 83 E. coli
isolates (98%); the two remaining isolated were positive for ESBL-
types TEM-52 and SHV-12, respectively. The most common
CTX-M genotypes were CTX-M-1 with 45% (n = 37), CTX-M-
15 with 29% (n = 24) and CTX-M-14 with 13% (n = 11). CTX-M-
2 was identified in 4 E. coli, CTX-M-27 in 3 E. coli and further
variants (CTX-M-3, CTX-M-8, CTX-M-32, CTX-M-55) were
identified in single isolates. The distribution of the CTX-M
genotypes is shown in Figure 2. Twenty-three isolates were
additionally positive for beta-lactamase TEM-1. Furthermore, in
16 isolates with increased MIC for ciprofloxacin the PMQR gene
aac(69)1b-cr was identified. The 85 E. coli were assigned to the four
phylogenic groups B2 (40%; n = 34), B1 (25%; n = 21), D (19%;
n = 16) and A (16%; n = 14). Additionally, we found that 67% of
the CTX-M-15-positive E. coli belonged to phylogenetic group B2,
in contrast with the CTX-M-1 positive strains that were assigned
to the four phylogenetic groups in nearly equal proportions (21–
30%).
Discussion
In the present study, an Asian mother tongue and frequent
consumption of pork were independently associated with the
acquisition of ESBL-positive E. coli in the community. ESBL-
positive organisms are widespread especially in some Asian
countries [1]. ESBL prevalence in Asia ranges between 13% and
79% [17]. Recent studies have shown that returning travelers and
patients from high endemic countries are at increased risk for
colonization with ESBL-positive Enterobacteriaceae. Tangden
et al. examined healthy Sweden-based travelers and found a
significant increase in ESBL colonization after returning from
Asian countries [3]. This effect may be epidemiologically of great
importance. A study from Switzerland showed that the transmis-
sion of ESBL-positive bacteria within the community significantly
exceeds nosocomial transmission rates [14]. Wickramasinghe et al.
analyzed stool samples from general practices and outpatients in
the UK and found significantly higher prevalence in patients with
Middle Eastern or South Asian background [18]. Our findings
support these results and show that an Asian family background
may yield an increased possibility of ESBL acquisition.
Recently, human colonization with ESBL-positive organisms
through the food chain has been widely discussed [4,7,19,20].
Most studies concerning ESBL-colonized meat found ESBL
organisms in living poultry or chicken meat. Studies from the
Netherlands even found significant similarities in ESBL genes in
strains from poultry and humans [5,6,7]. In a recent ESBL-
screening of retail chicken meat from German supermarkets
Figure 1. Recruitment diagram of cases and controls. EHEC, enterohemorrhagic E. coli. ESBL, extendend-spectrum beta-lactamase.
doi:10.1371/journal.pone.0074323.g001
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located in the same area as our study location, CTX-M-1 and
SHV-12 were found to be the predominant ESBL genotypes [4].
However, to our knowledge, there has yet not been an
experimental study that verified the possibility of colonization
through the consumption of contaminated food. Even though the
consumption of pork meat but not the consumption of poultry
meat was associated with ESBL colonization in this study our
result supports the possible transmission of ESBL-positive bacteria
through the food chain. The most commonly detected ESBL
genotype in European pigs is CTX-M-1 and was also the
predominant genotype in our study isolates [19].
Table 1. Comparison of basic parameters of excluded and included cases, controls and overall considered patients.
Cases Controls
Parameter Excluded (n = 142) Included (n = 85) P-value
Excluded
(n = 624) Included (n = 173) P-value
Median Age (IQR) 66 (52; 74) 62 (53; 72) 0.209 68 (53; 76) 67 (55; 73) 0.341a
Median CCI (IQR) 5 (2; 7) 5 (3; 7) 0.832 5 (2; 8) 4 (2; 6) 0.048a
Male sex, n (%) 76 (54) 42 (49) 0.585 232 (37) 72 (42) 0.165
Overall included and excluded patients
Parameter Excluded patients (n = 766) Included patients (n = 258) P-value
Median Age (IQR) 67 (53; 75) 66 (53; 72) p = 0.085 a
Median CCI (IQR) 5 (2; 8) 4 (3; 7) p = 0.112 a
Male sex n (%) n = 308 (40%) n = 114 (44%) p = 0.273
IQR, interquartile range. CCI, Charlson co-morbidity Index. P-value from Chi-square test or aWilcoxon rank sum test, respectively.
doi:10.1371/journal.pone.0074323.t001
Table 2. Demographic data for included cases colonized with ESBL-positive E. coli and controls without ESBL colonization.
Parameter Cases (N = 85) n (%) Controls (N = 170) n (%) P-value
Male 41 (48.2%) 72 (42.4%) 0.372
Median Age (IQR) 63 (53;72) 63 (56;73) 0.482a
Median BMI (IQR) 26 (22;29) 26 (22;29) 0.341a
Median CCI (IQR) 4 (2;6) 0 (2;7) 0.581a
Myocardial infarction 18 (10.6%) 9 (10.6%) 1.000
Congestive heart failure 21 (12.4%) 9 (10.6%) 0.680
Peripheral vascular disease 12 (7.1%) 7 (8.2%) 0.736
Cerebrovascular disease 4 (2.4%) 1 (1.2%) 0.523
Dementia 1 (0.6%) 0 (0.0%) 0.479
Chronic lung disease 24 (14.1%) 14 (16.5%) 0.619
Rheuma 4 (2.4%) 5 (5.9%) 0.150
Peptic ulcer 7 (4.1%) 2 (2.4%) 0.472
Mild liver disease 13 (7.6%) 4 (4.7%) 0.375
Diabetes without complication 26 (15.3%) 16 (18.8%) 0.474
Diabetes with chronic complication 9 (5.3%) 6 (7.1%) 0.572
Renal disease 52 (30.6%) 28 (32.9%) 0.703
Cancer 33 (19.4%) 15 (17.6%) 0.734
Moderate to severe liver disease 2 (1.2%) 1 (1.2%) 1.000
Metastatic cancer 20 (11.8%) 15 (17.6%) 0.198
AIDS 1 (0.6%) 0 (0.0%) 0.479
Hemiplegia 4 (2.4%) 1 (1.2%) 0.523
Leukemia 2 (1.2%) 2 (2.4%) 0.476
Lymphoma 8 (9.4%) 12 (14.1%) 0.680
IQR, interquartile range. BMI, Body Mass Index. CCI, Charlson co-morbidity Index. AIDS, acquired immune deficiency syndrome. P-value from Chi-square test or
aWilcoxon rank sum test, respectively.
doi:10.1371/journal.pone.0074323.t002
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Interestingly, Overdevest et al. found mostly CTX-M-1 in
human isolates from the community but CTX-M-14 in clinical
blood culture isolates [6,7]. Other studies analyzed patients
without healthcare contact in the previous 1 to 3 months
[21,22,23]. The ESBL genotypes they found were mainly CTX-
M-14 and CTX-M-15, and the detected risk factors for
colonization in these studies were recent hospital admission and
use of antibiotics. The risk factors found indicate that these studies
assessed cases of healthcare-acquired ESBL colonization. The
difference between the healthcare-acquired genotypes and geno-
types circling in the community might be associated with the
pressure deriving from the antibiotics used in the hospital [22].
Ceftazidime e.g. is a substrate for CTX-M-15 but not for CTX-M-
1 [24,25]. Studies on duration of ESBL colonization showed that
Table 3. Results of the questionnaire based interview: cases colonized with ESBL-positive E. coli and controls without ESBL
colonization.
Parameter Cases (N = 85) n (%) Controls (N = 170) n (%) P-value
Mother tongue (most commonly spoken language)
German 73(86%) 157(92%) 0.101
Northern/Central European 0 2(1%) 0.315
Southern European 1(1%) 1(1%) 0.616
Eastern European 0 6(4%) 0.080
Asian 11(13%) 4(2%) 0.001
Meat consumption $3 meals per week
Beef 1(1%) 13(8%) 0.032
Veal 1(1%) 2(1%) 1.000
Pork 50 (59%) 67(39%) 0.003
Poultry 21(25%) 37(22%) 0.597
Fish 10 (12%) 18(11%) 0.777
Travel destinations within the last 12 months
Europe 14 (17%) 34 (20%) 0.497
Asia 11 (13%) 11 (7%) 0.083
East Asia 1 (1%) 0 0.156
West Asia 9 (11%) 8 (5%) 0.076
South Asia 1 (1%) 0 0.156
North America 1 (1%) 2 (1%) 1.000
South America 1 (1%) 0 0.156
Africa 1 (1%) 4 (2%) 0.523
Australia/New Zealand 0 0 –
Health care related risk factors and carriage of other MDROs
within prior 12 months
Hospital stay 67 (79%) 118 (69%) 0.112
Antimicrobial therapy 76 (89%) 140 (82%) 0.140
Diarrhea 45 (53%) 61 (36%) 0.009
Urinary tract infection 37 (44%) 95 (56%) 0.063
MRSA 3 (3.5%) 2 (1.2%) 0.201
VRE 2 (2.4%) 1 (0.6%) 0.218
Clostridium difficile 1 (1.2%) 1 (0.6%) 0.616
Living situation
Alone 26 (31%) 59 (35%) 0.511
With meat eater 59 (69%) 110 (65%) 0.454
Only with vegetarians 0 0 –
In a long term care facility 0 1 (0.6%) 0.479
Animal contact
Domestic animals 29 (34.1%) 60 (35.3%) 0.853
Farm animals 5 (0.6%) 14 (0.8%) 0.500
MRSA, Methicillin resistant S.aureus; VRE, Vancomycin resistant Enterococcus. MDRO, multi drug resistant organism. P-value from Chi-square test. East Asia: China, Japan,
Mongolia, North Korea, South Korea, Taiwan. West Asia: Bahrain, Iraq, Israel, Yemen, Jordan, Qatar, Kuwait, Lebanon, Oman, Palestine, Saudi Arabia, Syria, Turkey, UAE,
Cyprus. South Asia: Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka.
doi:10.1371/journal.pone.0074323.t003
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ESBL-positive patients can be colonized for over 6 months
[26,27,28]. In order to analyze acquisition in the community, only
patients with a rather long period after their most recent positive
test for ESBL should be included. We took this into account and
analyzed a patient population that had not been detected positive
for ESBL-producing bacteria for at least 12 months. Most patients
in this study had been hospitalized in the previous year. However,
the most commonly reported factors associated with healthcare-
acquired ESBL colonization were not independently associated
with ESBL colonization in this study.
Limitations
This is a questionnaire-based study. Bias associated with this
kind of studies may result in unanticipated communication
barriers between the investigator and the respondents that yield
inaccurate results [29]. Possible bias in study design would lead to
e.g. recall bias, subjective perception of the interviewed patient or
influence of the interviewer. In order to minimize the risk of
questionnaire bias, we concentrated on short and simple questions
avoiding difficult or technical jargon. Nevertheless, some questions
concern rather complicated information like travel history or diet
habits. We therefore decided to perform a personal interview.
However, the generalizability of our results might be limited since
the analyzed cohort consisted of a selected population: hospitalized
patients with E. coli identified in clinical cultures obtained within
the first 72 hours of admission that did not fulfill any of the
exclusion criteria. Even though we excluded all patients with
known former ESBL colonization, we did not assess the previous
colonization status of all patients. Since many of the included cases
have been hospitalized previously, the possibility of a community-
onset healthcare-associated infection cannot be excluded. We
controlled for common risk factors associated with healthcare-
acquired ESBL colonization like prior hospital stay, antimicrobial
therapy, urinary tract infection and co-colonization with other
MDROs. Nevertheless we did not completely adjust for all
associated factors such as the previous application of a central
venous catheter. Due to the known ESBL colonization status and
related single room treatment an interviewer or interviewee
blinding was not realizable. We did not assess whether the patients
were infected or colonized with the respective pathogen. These
limitations may have introduced assessment bias and may
herewith have accounted for the observed associations between
carriage of ESBL and Asian background or consumption of meat.
Conclusion
In this exploratory case control study, colonization with ESBL
positive E. coli was mor commonly found in patients with an Asian
mother tongue. Frequent consumption of pork meat was another
factor independently associated with the colonization of ESBL-
positive E. coli. The mostly found ESBL genotype in the
community was CTX-M-1. Further confirmatory studies are
needed to prove these results.
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